Table 1.
Details of GEO datasets used in the study.
| Disease | GSE number | Source type | Samples size | Samples size | GPL Platform | Group |
|---|---|---|---|---|---|---|
| Sepsis | GSE65682 | Whole blood | Healthy people(n=42) | Sepsis patients(n=760) | GPL13667 | Discovery cohort |
| GSE95233 | Healthy people(n=22) | Sepsis patients(n=102) | GPL570 | Discovery cohort | ||
| GSE57065 | Healthy people(n=25) | Sepsis patients(n=82) | GPL570 | Validation cohort | ||
| GSE54514 | Healthy people(n=36) | Sepsis patients(n=127) | GPL6947 | Validation cohort | ||
| GSE13904 | Healthy people(n=18) | Sepsis patients(n=158) | GPL570 | Validation cohort | ||
| GSE185263 | Healthy people(n=44) | Sepsis patients(n=348) | GPL16791 | Validation cohort | ||
| GSE63311 | Healthy people(n=11) | Sepsis patients(n=37) | GPL10999 | Validation cohort | ||
| GSE48080 | PBMC | Healthy people(n=3) | Sepsis patients(n=20) | GPL4133 | Validation cohort | |
| GSE167363 | PBMC | Healthy people(n=2) | Sepsis patients(n=4) | GPL24676 | Discovery cohort | |
| ARDS | GSE32707 | Whole blood | Sepsis patients(n=58) | Sepsis+ARDS patients(n=31) | GPL10558 | Discovery cohort |
| GSE10474 | Sepsis patients(n=21) | Sepsis+ARDS patients(n=13) | GPL571 | Discovery cohort | ||
| E-MTAB-5273 | Healthy people(n=10) | Sepsis+ARDS patients(n=127) | A-MEXP-2210 | Validation cohort | ||
| E-MTAB-5274 | Healthy people(n=10) | Sepsis+ARDS patients(n=42) | A-MEXP-2210 | Validation cohort | ||
| GSE151263 | PBMC | Sepsis patients(n=2) | Sepsis+ARDS patients(n=2) | GPL20301 | Discovery cohort |